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Abstract
The authors tested single nucleotide polymorphisms (SNPs) in coding sequences of candidate genes
involved in glucose metabolism and obesity for associations with spina bifida (SB). Coding SNPs
on 12 candidate genes was investigated. Genotyping was performed on 507 children with SB and
their parents plus anonymous control DNAs from Hispanic and Caucasian individuals. The
transmission disequilibrium test was performed to test for genetic associations between transmission
of alleles and SB in the offspring (P < .05). A statistically significant association between Lys481
of HK1 (G allele), Arg109Lys of LEPR (G allele), and Pro196 of GLUT1 (A allele) was found (P
= .019, .039 and .040, respectively). Three SNPs on 3 genes involved with glucose metabolism and
obesity may be associated with increased susceptibility to SB.
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Neural tube defects (NTDs) constitute a group of malformations that result from failure of
normal neural tube closure between the third and fourth week of embryologic development.
Spina bifida (SB) and anencephaly are the most common types of NTDs in humans, with spina
bifida meningomyelocele (SBMM) being the most common form among individuals who
survive.1 They are multifactorial in origin with an incidence of approximately 1 to 2 per 1000
in the United States.1,2 The multifactorial inheritance pattern seen with NTDs implicates both
environmental and genetic factors. The methylenetetrahydrofolate reductase (MTHFR) gene
involved in folate metabolism has been previously associated with NTDs.1 Other
environmental factors with genetic controls that have been implicated are derangements in
glucose metabolism and obesity.3-5 Maternal obesity before pregnancy has been found to be
associated with an increased risk of approximately 2-fold or more for NTDs.5 Mexican
American women are of particular interest since they have the highest risk in the United States
for having a child with an NTD as well as the highest rates of obesity and type 2 diabetes
mellitus.2,6
At the cellular level, recent animal studies have demonstrated that increased glucose levels
disturb expression of genes that regulate embryonic development and cell cycle progression,
causing premature cell death of emerging organ structures.7-11 This results in defective
organogenesis. In preimplantation embryogenesis, hyperglycemia triggers exaggerated
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apoptosis at the blastocyst stage. Apoptosis at this early stage of development has been shown
to result in either spontaneous miscarriage or congenital malformations.9 In 1 postimplantation
diabetic model, alterations in apoptotic pathway-related gene expression directly resulted in
NTDs.12 Another postimplantation model of diabetes-associated anomalies suggested a role
for apoptosis triggered by the increased generation of oxygen free radicals.13
Single nucleotide polymorphisms (SNPs) can alter human response to disease. SNPs within
the coding region of genes are more likely to alter biological functions because only about 3%
to 5% of a person's DNA sequence codes for the production of proteins. We hypothesized that
coding SNPs (cSNPs) within genes involved in glucose metabolism and obesity are associated
with risk for development of SBMM. Twelve candidate genes known to regulate glucose
homeostasis and obesity were selected: solute carrier family 2, members 1 and 4 (GLUT1,
GLUT4), hexokinases 1 and 2 (HK1, HK2), glyceraldehyde 3 phosphate dehydrogenase
(GAPD), insulin (INS), insulin receptor (INSR), leptin (LEP), leptin receptor (LEPR),
transforming protein 53 (TP53), superoxide dismutase 2 (SOD2), and catalase (CAT).
The GLUT genes, also known as solute carrier family (SLC2A) genes, are facilitated glucose
transporters.14 Hexokinases and GAPD assist in blood glucose regulation. Hexokinases
phosphorylate glucose, committing glucose to the glycolytic pathway. GAPD catalyzes an
important energy-yielding step in carbohydrate metabolism. HK1 has been found to be a Gli2-
responsive gene, which has an important role in neurogenesis,15 and HK2 facilitates glucose
uptake in response to insulin. Leptin is an antiobesity hormone that exerts insulin- and glucose-
lowering effects by enhancing peripheral insulin sensitivity and glucose uptake. The leptin
receptor is a single transmembrane protein that also plays a role in glucose metabolism.16,
17 Binding of insulin to the insulin receptor stimulates glucose uptake.
The process of neural tube formation relies on the balancing of cell proliferation and cell death
events among cells on the neural ridge. One hypothesis for the cause of diabetes-associated
malformations, including NTDs, is hyperglycemia-induced apoptosis.12 A TP53 gene-
dependent apoptosis pathway has been identified in murine embryos.18 An alternative effect
of this is generation of reactive oxygen species (ROS). Diabetes may induce teratogenesis by
disturbing the embryonic metabolism of arachidonic acid, prostaglandin, or myoinositiol by
increased DNA mutation rates possibly due to excess production of ROS. The ROS pathway
is of particular importance because antioxidants may protect from disturbances of both the
inositol and the arachidonic pathway. The intracellular antioxidant defense mechanism is
attained mainly by the scavenging enzymes superoxide dismutase and catalase.19
Accentuation of oxidative injury may occur when catalase and superoxide dismutase functions
are impaired.
In summary, we investigated coding polymorphisms in 12 candidate genes involved in glucose
metabolism and obesity for their association with SB by using the trio-based transmission
disequilibrium test (TDT).
MATERIALS AND METHODS
Patients with SBMM and their parents were enrolled into the study from 1996 to 2006.
Informed consent was obtained, with the Institutional Review Board (IRB) of University of
Texas Health Science Center at Houston being the primary IRB. Blood samples were obtained
from the patients and both parents when possible, and genomic DNA was extracted from blood
lymphocytes using the Puregene DNA extraction kit (Gentra Systems Inc, Minneapolis, MN).
When a parent was not available for blood sampling, a saliva DNA collection kit (Oragene)
was sent to the family to complete the family trio. Working DNA stocks of 10 ng/μL were
prepared for polymerase chain reaction (PCR). Our affected case population consisted of 207
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males, 227 females, and 73 of unknown gender, for a total of 507 families. Most of the patients
were North American Caucasians of European descent and Mexican Americans from northern
Mexico and were recruited in Houston, Texas; Los Angeles, California; and Toronto, Canada.
The location and size of spinal defect were available for most patients (Table 1). In addition,
anonymous control DNA from 92 Hispanic individuals from the Houston area and 93
Caucasian individuals from the Human Variation Panel-Caucasian Panel of 100 (HD100CAU)
without a personal or family history of NTDs was used as controls. Sociodemographic as well
as pregnancy history, maternal health history, and maternal exposures were obtained from the
mothers of the affected patients. Information regarding vitamin supplementation during the
pregnancy was not collected for the initial study; however, a survey to collect this information
is currently ongoing.There was no excess reporting of maternal diabetes. Genotyping quality
control was accomplished using DNA samples from 30 families collected by the Centre d'Etude
du Polymorphisme Humain (CEPH) that were also used in the HapMap (haplotype map of the
human genome) project.
SNP Selection
We searched the public database (http://www.ncbi.nlm.nih.gov/SNP/ and
http://genome.cse.ucsc.edu/) for cSNPs in each of our candidate genes. For this study, we
selected SNPs that met several criteria: (1) potentially functional SNPs such as coding SNPs
and SNPs in the promoter region, (2) SNPs that are validated, (3) SNPs with a reported
population frequency of minor allele greater than 5% to allow power of statistical analyses for
our patients' population size, and (4) SNPs that are reported to have an impact on the function
of our selected genes. Therefore, some genes have only 1 SNP, while others have many (eg,
LEPR). Both synonymous and nonsynonymous SNPs were chosen, with nonsynonymous
SNPs being those that result in an amino acid change. A total of 38 cSNPs, most of them with
heterozygosity present in at least 5% of the CEU population (30 trios of Utah residents of
northern and western European ancestry from the CEPH collections), were chosen (Table 2).
Information on the heterozygosities of the selected SNPs for Mexican Americans was not
available at the time of SNP selection and is still unavailable.We successfully examined 7
cSNPs in the INSR and LEPR genes, 4 in SOD2, 2 in INS and HK1, and 1 in LEP, HK2,
GLUT1, TP53, and GAPD. Once we identify SNPs that are significantly associated with
SBMM, we will regenotype SNPs spanning the whole gene with high density (eg, GLUT1,
HK1, and LEPR).
DNA Genotyping
SNP genotyping was carried out using a recently developed high-throughput SNPlex
Genotyping System protocol (ABI) based on an oligonucleotide ligation/PCR/probe
hybridization assay that can interrogate 48 SNPs simultaneously in 1 reaction. Working DNA
stocks of 50 ng were used for each SNPlex reaction. PCR amplification was performed in a
10-μL reaction volume. Raw genotyping files were generated by running the samples through
a 3730 xl DNA analyzer, and GeneMapper version 4.0 software was used to analyze the raw
data and assign SNP genotypes.The genotypes initially assigned by the software were
examined by at least 2 investigators before exporting and compiling for statistical analyses.
Eleven cSNPs were excluded from statistical analysis because they did not meet our criteria
for having at least an 85% genotype call rate from GeneMapper.
Statistical Analysis
All analyses were conducted on the entire sample set (Caucasians and Hispanics) and stratified
by parentidentified ethnicity of the child.We evaluated genotypes in both a codominant and
dominant fashion among all tested samples. The overtransmitted alleles are the tested at-risk
alleles.The significance level was set at P < .05.
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For family-based analyses, we used the reconstruction-combined transmission disequilibrium
test (RC-TDT). The TDT is a family-based association test that detects a linkage between a
marker and a disease-susceptibility locus in the presence of linkage disequilibrium between
the 2 loci. It is not subject to population stratification.The RC-TDT permutes information on
missing parents and is considered to be a robust method for assessing transmission in data
containing both complete and incomplete trios.20,21
RESULTS
To verify the SNPlex genotyping platform accuracy, we included 45 CEPH CEU individuals
used in the HapMap project for comparison. For all the SNPs successfully genotyped, 100%
concordance was observed. The 27 SNPs genotyped our patient samples and showed Hardy-
Weinberg equilibrium. Duplicates of positive controls used in separate SNPlex experiments
produced reproducible genotypes.
In our RC-TDT analysis, our experiments showed higher transmission from parents to
offspring with SBMM of the G allele at Arg109Lys of LEPR, the A allele at Pro196 of
GLUT1, and the G allele at Lys481 of HK1, suggesting possible risk association to SBMM.
Although not statistically significant, a trend of significance was observed in the transmission
of the G allele at Arg223Gln of LEPR. No statistical significances were found in the remaining
SNPs (Table 3).
DISCUSSION
We analyzed 27 genetic variants thought to have functional consequences in 10 genes involved
in glucose homeostasis and obesity to explore their relationship with SBMM. Three SNPs in
3 different genes showed statistically significant transmission disequilibrium from parents to
affected offspring. Here, we report the association for the G allele at Arg109Lys of LEPR, the
A allele at Pro196 of GLUT1, and the G allele at Lys481 of HK1 with SBMM. Both Pro196
and Lys481 are synonymous SNPs, while Arg109Lys results in an amino acid change.
LEPR
Kawamura and colleagues22 demonstrated that leptin promotes the development of mouse
preimplantation embryos in vitro together with the expressed LEPR, suggesting that the leptin
signaling pathway plays a critical role in embryonic development before fat development and
feeding. Park and colleagues23 sequenced the LEPR gene in patients with type 2 diabetes
mellitus (DM) and in nondiabetic controls in an effort to identify genetic polymorphisms in a
potential candidate gene for obesity and type 2 DM.They found that Arg109Lys was weakly
associated with body mass index among nondiabetic controls. We genotyped this same SNP
in our patients and found a significant association with Arg109Lys (amino acid change from
arginine to lysine at codon 109). Our patients had significantly higher 109Lys (G allele)
transmitted from parents to affected offspring. Lakka and colleagues24 showed that the 109Arg
variant of LEPR exhibits higher activities than the 109Lys variant in terms of improved insulin
sensitivity and glucose tolerance.Therefore, inheriting this SNP with its resultant amino acid
change may alter the embryologic response to glucose homeostasis with subsequent
development of SBMM.
A previous association study of SB with the LEP and LEPR genes did not find association
using microsatellites proximal to these genes.25 However, this study was based on a very small
sample size (approximately 50 cases and 125 controls), and the power for significant statistical
analyses was minimal. In addition, the microsatellite markers used in the study were more than
40 Kbp away from the LEPR gene, which also limits the power of the linkage disequilibrium
study.The LEPR gene spans more than 200 Kbp on human chromosome 1; therefore, testing
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SNP markers inside the gene is better than using remote microsatellite markers to study disease
association.
GLUT1
Animal models have demonstrated that GLUT1 is present in both preimplantation and
postimplantation embryos.26-28 Its expression has been identified in the neural tube of rat
embryos during the early organogenesis period.28 Chi and colleagues29 showed that decreased
expression of GLUT1 in the mouse blastocyst results in decreased glucose transport and an
increase in apoptosis. They were also able to demonstrate that these preimplantation apoptotic
events were linked to malformations, including NTDs. Heilig and colleagues30 produced
Glut1-deficient transgenic mice in the range reported with maternal diabetes and demonstrated
that reduced embryonic glucose transporter 1 was associated with the appearance of apoptosis
and neural tube defects. They showed that isolated Glut1 suppression in mice impaired
embryonic development from the earliest stages on, leading to developmental malformations
including NTDs, and they concluded that hyperglycemic suppression of embryonic Glut1 may
play an important role in the malformations that develop in response to maternal diabetes. We
showed an overtransmission of the A allele of Pro196 from parents to offspring with SBMM.
It involved no amino acid change, so the function of this is not quite known. It could be in
linkage disequilibrium (LD) with an unknown risk variant of the GLUT1 gene that has yet to
be identified by resequencing the gene of the patients having the risk allele.This change could
also affect transcription or splicing. Recent studies have revealed these heretofore unknown
effects sometimes caused by synonymous changes in genes. Analyses of the 2 rs2229682
(Pro196) polymorphic variants using the Exonic Splicing Enhancer Finder program
(ESEFinder; http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home)31 indicate
that the A allele variant has higher SRp40 binding (from 0.5317 to 3.0862) and Splicing Factor
2/Alternate Splicing Factor (SF2/ASF) binding (from 1.1734 to 2.4703) and is predicted to
enhance splicing of this exon. The G allele variant has values less than the thresholds (1.956
and 2.67, respectively) and is not considered an exonic splicing enhancer. Use of other software
programs (PESX, RESCUE-ESE, and FAS-ESS)32-35 to examine exonic splice enhancers/
silencers resulted in similar conclusions regarding the potential functional significance of this
change.As recently reported, studies performed with other genes have demonstrated that silent
mutations can affect transcription and splicing.36-38
HK1
HK1 expression is induced by Gli2 and is detected in distinct groups of cells in the neural tube
of frog embryos.15 Since the primary energy source of the brain is derived from glucose
metabolism, and hexokinase catalyses the first and rate-limiting step in this process, there is
potentially a link between the regulation of neuronal induction and differentiation.We showed
an overtransmission of the G allele of Lys481 from parents to affected offspring. It involved
no amino acid change, so the functional consequence of this change is not known. It is possible
that the Lys481 SNP is in LD with an unknown SBMM variant of the HK1 gene that has yet
to be identified by resequencing the gene of the patients having the risk allele. This variant
could also affect transcription or splicing. Analyses of the 2 rs748235 (Lys481) polymorphic
variants using ESEFinder indicate that the A allele variant does not constitute any ESE binding
motif with a predicted value of 1.0514. However, the G allele variant is predicted to bind the
exonic splicing enhancer protein SF2/ASF (value of 2.7479).31
Derangements in glucose metabolism and obesity have been associated with birth defects such
as SB.3-5 Twofold or more SB cases were attributed to maternal obesity in a large-scale study
involving more than 10 000 cases from the National Birth Defects Prevention Study
(1997-2002).39 Among the highest risk are Mexican American women having a child with an
NTD, and the same group also has the highest rates of obesity and type 2 DM.2,6 The cellular
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mechanism of the disturbed glucose homeostasis leading to NTDs began to emerge from recent
animal studies demonstrating that increased glucose levels disturb the expression of genes that
regulate embryonic development and cell cycle progression, causing premature cell death of
emerging organ structures.7-11 Disrupted apoptotic pathway-related gene expression was
shown in a postimplantation diabetic mouse model to result directly in NTDs.12 Increased
generation of free radical oxygen species, as shown in a postimplantation model associated
with diabetic pregnancies, can trigger cellular apoptosis and organ anomalies.13 More evidence
has begun to link cell survival and apoptotic pathway kinases, such as serine/threonine kinase
Akt, Bcl2 associated-X protein, and c-Jun N-terminal kinase, with the activities of leptin,
glucose transporters, and hexokinases in disrupted glucose homeostasis.40-45 Akt increases
mitochondria-associated hexokinase activity. The antiapoptotic activity of Akt requires the
first committed step of glucose metabolism catalyzed by hexokinase.42 Akt can prevent cell
death following growth factor withdrawal and was found to regulate multiple steps in glycolysis
via posttranscriptional mechanisms, including localization of GLUT1 to the cell surface and
maintenance of hexokinase function.40 Thus, our findings may support the theory that excess
apoptosis is a key mechanism in the induction of NTDs.
CONCLUSION
In summary, the RC-TDT analyses were able to show a statistically significant association with
SBMM for 3 SNPs on 3 genes. Our study is limited by the fact that it is not able to differentiate
the specific contribution to the development of SBMM from the overtransmitted alleles on the
SNPs versus maternal or fetal contributions during formation of the neural tube. This study
was undertaken to identify risk polymorphisms associated with SBMM and not to attempt to
establish a cause and effect relationship. Future testing may include genotyping denser SNPs
to locate SNPs that are closer to the risk variant.The design of functional assays to test if the
variants affect splicing and resequencing of exons of these genes to find risk variants are other
areas of interest for future research. Case-control analyses are currently ongoing in our
laboratory.
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Table 1
Characteristics of the Study Population
Trios Duos Total
Race
Caucasian 114 76 190
Mexican American 138 146 284
African American 3 12 15
Asian American 2 1 3
Other 3 2 5
Unknown 2 8 10
Gender
Male 110 97 207
Female 119 108 227
Unknown 33 40 73
SB Lesion
≥L1 73 72 144
≤L2 169 147 316
Mixeda 3 4 7
Unknown 18 22 40
a
Mixed SB lesion = lesion spanning L1 and L2.
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Table 2
Genes and Coding SNPs Investigated
Gene dbSNP ID SNP Type Amino Acid Polymorphism Population Heterozygosity
INS rs11557616 s Leu105 NA
INS rs11557608 s Tyr103 NA
INS rs11557614 ns Val38Ala NA
INS rs13306444 ns Thr23Ala NA
INS rs11557610 s Pro9 NA
INSR rs1799817 s His1085 0.392
INSR rs1799815 s Tyr1011 0.077
INSR rs2229433 s Ala906 0.092
INSR rs16994192 s Ile881 0.106
INSR rs13306457 s Asn865 0.178
INSR rs2229434 s Thr790 0.068
INSR rs2963 s Leu640 0.200
INSR rs2229435 s Ser366 0.032
INSR rs2229428 s Ser296 0.013
INSR rs891087 s Asp261 0.216
LEP rs17151919 ns Met94Val 0.055
LEPR rs1137100 ns Arg109Lys 0.498
LEPR rs1137101 ns Arg223Gln 0.450
LEPR rs3790419 s Ser343 0.308
LEPR rs8179183 ns Asn656Lys 0.825
LEPR rs1805095 s Tyr986 0.015
LEPR rs6413506 s Ser1008 0.067
LEPR rs1805096 s Pro1019 0.483
GLUT1 rs2229682 s Pro196 0.335
GLUT1 rs1385129 s Ala15 0.379
GLUT4 rs8192702 ns Val358Ala 0.020
HK1 rs748235 s Lys481 0.325
HK1 rs1054203 ns Met776Leu 0.020
HK2 rs11887192 s Asp251 0.478
HK2 rs2229629 ns Lys844Arg 0.375
GAPD rs1803621 s Phe295 0.391
CAT rs11032709 s Leu419 0.119
P53 rs1800371 ns Ser47Pro 0.014
SOD2 rs5746129 ns Trp156Arg 0.022
SOD2 rs4987023 ns Arg76Gly 0.010
SOD2 rs5746097 ns Val66Glu 0.012
SOD2 rs1799725 ns Ala16Val 0.484
SOD2 rs5746096 ns Ile10Ser 0.012
Abbreviations: NA, information not available; ns, nonsynonymous; s, synonymous; SNP, single nucleotide polymorphism.
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Table 3
Statistically Significant Transmission Disequilibrium Test (TDT) Genes and Their Single Nucleotide Polymorphisms
(SNPs)
Gene dbSNP ID Amino Acid
Reconstruction-Combined
TDT (P Value) Overtransmitted Allele
LEPR rs1137100 Arg109Lys 0.0393 A
rs1137101 Arg223Gln 0.0585 G
rs3790419 Ser343 0.9150 G
rs8179183 Asn656Lys 0.7830 C
rs1805095 Tyr986 — —
rs6413506 Ser1008 — —
rs1805096 Pro1019 0.3960 C
GLUT1 rs2229682 Pro196 0.0396 A
rs1385129 Ala15 0.7540 A
HK1 rs748235 Lys481 0.0187 G
rs1054203 Met776Leu — —
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